Sterling Capital Management’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.52K Sell
191
-29
-13% -$360 ﹤0.01% 2928
2026
Q1
$2.49K Sell
220
-238
-52% -$2.62K ﹤0.01% 2943
2025
Q4
$3.67K Hold
458
﹤0.01% 2972
2025
Q3
$21.9K Buy
458
+337
+279% +$7.48K ﹤0.01% 2094
2025
Q2
$1.51K Buy
121
+39
+48% +$562 ﹤0.01% 2989
2025
Q1
$1.43K Sell
82
-64
-44% -$1.9K ﹤0.01% 2696
2024
Q4
$5.56K Buy
146
+130
+813% +$6.68K ﹤0.01% 2431
2024
Q3
$535 Buy
+16
New +$673 ﹤0.01% 2847

Other funds holding KRRO

Sterling Capital Management's KRRO Position: Q2 2026 in Review

Sterling Capital Management reduced its Korro Bio (KRRO) stake by 13% in Q2 2026, selling an estimated $360 and leaving 191 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

Sterling Capital Management first reported a position in KRRO in Q3 2024 and has held it in 8 quarters since. The position peaked at $21.9K in Q3 2025. 17 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Sterling Capital Management held 191 shares of Korro Bio worth $2.52K as of Q2 2026.
  • Sterling Capital Management sold 29 Korro Bio shares in Q2 2026, an estimated $360.
  • Korro Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2928 holding.
  • Sterling Capital Management first reported a position in Korro Bio in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Korro Bio position peaked at $21.9K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.